調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023

微生物迅速検査の世界市場予測（～2023年）

◆タイトル：Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023
◆商品コード：MD-6602
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年9月12日
◆ページ数：189
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥638,450	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥751,450	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥920,950	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、微生物迅速検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、手法（培養、増殖力）分析、製品（自動微生物同定・ASTシステム、PCR、試薬）分析、用途（臨床診断、環境）分析、エンドユーザー（ラボ、病院、工業）分析、微生物迅速検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global rapid microbiology testing market is expected to USD 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%. Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing.
This report broadly segments the rapid microbiology testing market into products, methods, applications, end users, and regions.

Based on product, the global rapid microbiology testing market is segmented into instruments, reagents & kits, and consumables. In 2018, the instruments segment is expected to account for the largest share of the market owing to factors such as the significant adoption of modern laboratory instruments in the research and academic sectors (coupled with growing industry-academia collaborations for genomic research) and the ongoing trend of laboratory automation among clinical laboratories.

Based on method, the global rapid microbiology testing market is divided into five segments growth-based, viability-based, cellular component-based, nucleic acid-based, and other testing methods. The growth-based rapid microbiology testing segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.

On the basis of application, the rapid microbiology testing market is segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, cosmetics and personal care products testing, environmental applications, research applications, and other applications. The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period. This can primarily be attributed to the increasing use of rapid microbiology testing for the diagnosis of infectious diseases in humans; rising emphasis on effective and early disease diagnosis across major markets; and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis.

The rapid microbiology testing market, by end user, is segmented into diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical companies, CROs, and other end users. In 2018, the diagnostic laboratories & hospitals segment is expected to account for the largest share of the rapid microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements in rapid microbial testing.

The report covers the rapid microbiology testing market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global rapid microbiology testing market in 2018. Technological advancements in the field of rapid microbial testing, the rising incidence of infectious diseases, and growing food safety concerns are driving the growth of the rapid microbiology testing market in North America. Additionally, easy accessibility and high adoption of advanced diagnostic technologies owing to the significant per capita annual healthcare expenditure by the US and Canadian governments are increasing the adoption of rapid microbiology testing in this region. The Asia Pacific region is expected to grow at the highest CAGR due to the increasing healthcare expenditure and growing initiatives to promote the use of advanced rapid microbiology testing technologies in Asia Pacific countries.

However, reimbursement concerns and the high cost of rapid microbiology testing products are the major factors restricting market growth.

As of 2017, some of the major players operating in this market include bioMérieux SA (France), Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).

【レポートの目次】

Table of Contents

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.3 Market Size Estimation
2.1.4 Product-Based Market Estimation
2.1.5 Volume-Based Market Estimation
2.1.6 Primary Research Validation
2.2 Market Breakdown and Data Triangulation
2.3 Research Limitations and Assumptions
2.3.1 Limitations
2.3.2 Assumptions

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 37)
4.1 Rapid Microbiology Testing Market Overview
4.2 Regional Analysis: Rapid Microbiology Testing Market, By Product
4.3 Rapid Microbiology Testing Reagents Market, By Type
4.4 Asia Pacific: Rapid Microbiology Testing Market, By Method, 2018
4.5 Rapid Microbiology Testing Market, By Application
4.6 Regional Analysis: Rapid Microbiology Testing Market, By End User
4.7 Rapid Microbiology Testing Market, By Country

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Infectious Diseases
5.2.1.2 Technological Advancements
5.2.1.3 Increasing Food Safety Concerns
5.2.1.4 Funding, Research Grants, and Public-Private Investments
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Policies
5.2.3 Opportunities
5.2.3.1 Government Initiatives for the Detection of Antimicrobial Resistance
5.2.3.2 Emerging Countries
5.2.3.3 Bioterrorism Surveillance
5.2.4 Challenges
5.2.4.1 High Cost of Rapid Microbiology Testing Instruments
5.2.5 Burning Issues
5.2.5.1 Bundled Sales By Market Giants
5.2.5.2 Stringent Policies and Expected Regulatory Changes

6 Rapid Microbiology Testing Market, By Method (Page No. – 53)
6.1 Introduction
6.2 Growth-Based Rapid Microbiology Testing
6.3 Cellular Component-Based Rapid Microbiology Testing
6.4 Nucleic Acid-Based Rapid Microbiology Testing
6.5 Viability-Based Rapid Microbiology Testing
6.6 Other Rapid Microbiology Testing Methods

7 Rapid Microbiology Testing Market, By Product (Page No. – 62)
7.1 Introduction
7.2 Instruments
7.2.1 Automated Microbial Identification and Antimicrobial Susceptibility Testing Systems
7.2.2 Mass Spectrometers
7.2.3 Pcr Systems
7.2.4 Bioluminescence- and Fluorescence-Based Detection Systems
7.2.5 Cytometers
7.2.6 Active Air Samplers
7.2.7 Other Instruments
7.3 Reagents & Kits
7.3.1 Sterility Testing Reagents & Kits
7.3.2 Other Reagents & Kits
7.4 Consumables

8 Rapid Microbiology Testing Market, By Application (Page No. – 76)
8.1 Introduction
8.2 Clinical Disease Diagnosis
8.3 Food & Beverage Testing
8.4 Pharmaceutical & Biological Drug Testing
8.5 Environmental Testing
8.6 Cosmetics & Personal Care Products Testing
8.7 Research Applications
8.8 Other Applications

9 Rapid Microbiology Testing Market, By End User (Page No. – 87)
9.1 Introduction
9.2 Diagnostic Laboratories & Hospitals
9.3 Food & Beverage Companies
9.4 Pharmaceutical & Biotechnology Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Rapid Microbiology Testing Market, By Region (Page No. – 95)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Rest of the World

11 Competitive Landscape (Page No. – 139)
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Product Launches, Approvals, and Enhancements
11.3.2 Acquisitions
11.3.3 Collaborations and Agreements
11.3.4 Expansions

12 Company Profiles (Page No. – 143)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Abbott Laboratories
12.2 Becton, Dickinson and Company
12.3 Biomérieux
12.4 Bruker Corporation
12.5 Charles River Laboratories International, Inc.
12.6 Danaher Corporation
12.7 Don Whitley Scientific Limited
12.8 Merck KGaA
12.9 Neogen Corporation
12.10 Quidel Corporation
12.11 Rapid Micro Biosystems, Inc.
12.12 Sartorius Group
12.13 Thermo Fisher Scientific
12.14 TSI, Inc.
12.15 Vivione Biosciences, LLC

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 181)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (90 Tables)

Table 1 Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 2 Types of Technologies Used in Various Rapid Microbiology Testing Methods
Table 3 Growth-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 4 Cellular Component-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 5 Nucleic Acid-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 6 Viability-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 7 Other Rapid Microbiology Testing Methods Market, By Region, 2016–2023 (USD Million)
Table 8 Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 9 Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 10 Rapid Microbiology Testing Instruments Market, By Region, 2016–2023 (USD Million)
Table 11 Rapid Microbiology Testing Market for Automated Microbial Id/Ast Systems, By Region, 2016–2023 (USD Million)
Table 12 Rapid Microbiology Testing Market for Mass Spectrometers, By Region, 2016–2023 (USD Million)
Table 13 Rapid Microbiology Testing Market for Pcr Systems, By Region, 2016–2023 (USD Million)
Table 14 Rapid Microbiology Testing Market for Bioluminescence- and Fluorescence-Based Detection Systems, By Region, 2016–2023 (USD Million)
Table 15 Rapid Microbiology Testing Market for Cytometers, By Region, 2016–2023 (USD Million)
Table 16 Rapid Microbiology Testing Market for Active Air Samplers, By Region, 2016–2023 (USD Million)
Table 17 Rapid Microbiology Testing Market for Other Instruments, By Region, 2016–2023 (USD Million)
Table 18 Rapid Microbiology Testing Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 19 Rapid Microbiology Testing Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 20 Rapid Microbiology Testing Market for Sterility Testing Reagents & Kits, By Region, 2016–2023 (USD Million)
Table 21 Rapid Microbiology Testing Market for Other Reagents & Kits, By Region, 2016–2023 (USD Million)
Table 22 Rapid Microbiology Testing Consumables Market, By Region, 2016–2023 (USD Million)
Table 23 Rapid Microbiology Testing Market, By Application, 2016–2023 (USD Million)
Table 24 Rapid Microbiology Testing Market for Clinical Disease Diagnosis, By Region, 2016–2023 (USD Million)
Table 25 Rapid Microbiology Testing Market for Food & Beverage Testing, By Region, 2016–2023 (USD Million)
Table 26 Rapid Microbiology Testing Market for Pharmaceutical & Biological Drug Testing, By Region, 2016–2023 (USD Million)
Table 27 Rapid Microbiology Testing Market for Environmental Testing, By Region, 2016–2023 (USD Million)
Table 28 Rapid Microbiology Testing Market for Cosmetics & Personal Care Products Testing, By Region, 2016–2023 (USD Million)
Table 29 Rapid Microbiology Testing Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 30 Rapid Microbiology Testing Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 31 Rapid Microbiology Testing Market, By End User, 2016–2023 (USD Million)
Table 32 Rapid Microbiology Testing Market for Diagnostic Laboratories & Hospitals, By Region, 2016–2023 (USD Million)
Table 33 Rapid Microbiology Testing Market for Food & Beverage Companies, By Region, 2016–2023 (USD Million)
Table 34 Rapid Microbiology Testing Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 35 Rapid Microbiology Testing Market for Contract Research Organizations, By Region, 2016–2023 (USD Million)
Table 36 Rapid Microbiology Testing Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 37 Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 38 North America: Rapid Microbiology Testing Market, By Country, 2016–2023 (USD Million)
Table 39 North America: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 40 North America: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 41 North America: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 42 North America: Rapid Microbiology Testing Market, By Application, 2016–2023 (USD Million)
Table 43 North America: Rapid Microbiology Testing Market, By End User, 2016–2023 (USD Million)
Table 44 US: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 45 US: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 46 US: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 47 Canada: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 48 Canada: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 49 Canada: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 Europe: Rapid Microbiology Testing Market, By Country, 2016–2023 (USD Million)
Table 51 Europe: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 52 Europe: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 53 Europe: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 54 Europe: Rapid Microbiology Testing Market, By Application, 2016–2023 (USD Million)
Table 55 Europe: Rapid Microbiology Testing Market, By End User, 2016–2023 (USD Million)
Table 56 Germany: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 57 Germany: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 58 Germany: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 59 France: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 60 France: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 61 France: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 62 UK: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 63 UK: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 64 UK: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 65 RoE: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 66 RoE: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 68 Asia Pacific: Rapid Microbiology Testing Market, By Country, 2016–2023 (USD Million)
Table 69 Asia Pacific: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 70 Asia Pacific: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 71 Asia Pacific: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 72 Asia Pacific: Rapid Microbiology Testing Market, By Application, 2016–2023 (USD Million)
Table 73 Asia Pacific: Rapid Microbiology Testing Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 75 Japan: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 76 Japan: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 China: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 78 China: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 79 China: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 80 India: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 81 India: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 82 India: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 83 RoAPAC: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 84 RoAPAC: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 85 RoAPAC: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 86 RoW: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 87 RoW: Rapid Microbiology Testing Market, By Product, 2016–2023 (USD Million)
Table 88 RoW: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 89 RoW: Rapid Microbiology Testing Market, By Application, 2016–2023 (USD Million)
Table 90 RoW: Rapid Microbiology Testing Market, By End User, 2016–2023 (USD Million)

List of Figures (42 Figures)

Figure 1 Rapid Microbiology Testing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Rapid Microbiology Testing Market
Figure 4 Top-Down Approach Market Size Estimation: Rapid Microbiology Testing Market
Figure 5 Data Triangulation Methodology
Figure 6 Rapid Microbiology Testing Market, By Product, 2018 vs 2023
Figure 7 Rapid Microbiology Testing Instruments Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Rapid Microbiology Testing Market, By Method, 2018 (USD Million)
Figure 9 Rapid Microbiology Testing Market, By Application, 2018 vs 2023
Figure 10 Rapid Microbiology Testing Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Rapid Microbiology Testing Market, By Region
Figure 12 Incidence of Infectious Diseases, the Key Factor Driving the Growth of the Rapid Microbiology Testing Market
Figure 13 Reagents & Kits Segment to Witness High Growth in the Asia Pacific Market During the Forecast Period
Figure 14 Sterility Testing Reagents & Kits Will Grow at A Faster Rate in the Rapid Microbiology Testing Market in 2018
Figure 15 Growth-Based Segment Will Dominate the Asia Pacific Rapid Microbiology Testing Method Market During in 2018
Figure 16 Clinical Disease Diagnostics Segment to Hold Largest Share of the Rapid Microbiology Testing Market in 2018
Figure 17 North America to Dominate the End-User Market in 2018
Figure 18 China to Witness Highest Growth During the Forecast Period (2018 to 2023)
Figure 19 Rapid Microbiology Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Deaths Attributable to Antimicrobial Resistance Every Year By 2050
Figure 21 Percentage Change in Annual Healthcare Expenditure: Developed vs Developing Countries (2005–2015)
Figure 22 Growth-Based Rapid Microbiology Testing Segment to Dominate the Market During the Forecast Period
Figure 23 Instruments Segment to Dominate the Rapid Microbiology Testing Products Market
Figure 24 Clinical Disease Diagnosis Applications to Dominate the Rapid Microbiology Testing Market During the Forecast Period
Figure 25 Diagnostic Laboratories & Hospitals are Estimated to Form the Largest End-User Segment in the Rapid Microbiology Testing Market
Figure 26 North America: Rapid Microbiology Testing Market Snapshot
Figure 27 Europe: Rapid Microbiology Testing Market Snapshot
Figure 28 Asia Pacific: Rapid Microbiology Testing Market Snapshot
Figure 29 RoW: Rapid Microbiology Testing Market Snapshot
Figure 30 Key Developments By Leading Market Players in the Rapid Microbiology Testing Market, 2015–2018
Figure 31 Rapid Microbiology Testing Market Share, By Key Player, 2017
Figure 32 Abbott Laboratories: Company Snapshot
Figure 33 Becton, Dickinson and Company: Company Snapshot
Figure 34 Biomérieux: Company Snapshot
Figure 35 Bruker Corporation: Company Snapshot
Figure 36 Charles River Laboratories International, Inc.: Company Snapshot
Figure 37 Danaher Corporation: Company Snapshot
Figure 38 Merck KGaA: Company Snapshot
Figure 39 Neogen Corporation: Company Snapshot
Figure 40 Quidel Corporation: Company Snapshot
Figure 41 Sartorius Group: Company Snapshot
Figure 42 Thermo Fisher Scientific: Company Snapshot

★調査レポート[微生物迅速検査の世界市場予測（～2023年）] ( Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023 / MD-6602) 販売に関する免責事項

[微生物迅速検査の世界市場予測（～2023年）] ( Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023 / MD-6602) についてEメールでお問い合わせ

◆関連調査資料◆

微生物検査/臨床微生物学の世界市場予測（～2023年）
MD-3092 / MarketsandMarkets / 2018年6月27日 / MarketsandMarketsが発行した当調査レポートでは、微生物検査/臨床微生物学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途（製薬、臨床、製造、環境）別分析、疾患（呼吸器疾患、STD、UTI）別分析、製品（機器、分析装置、試薬）別分析、エンドユーザー（病院、診断ラボ、学術機関）別分析、微生物検査/臨床微生物学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global clinical microbiology market is projected to grow at a CAGR of 6.4% in the next five years”The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the...

In Vitro診断（IVD）の世界市場予測（～2023年）：IVD装置、IVD試薬
MAM-MD-3609 / MarketsandMarkets / 2018年3月27日 / MarketsandMarketsが発行した当調査レポートでは、In Vitro診断（IVD）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、In Vitro診断（IVD）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion...

血液分析装置・試薬の世界市場予測（～2023年）
MD-2479 / MarketsandMarkets / 2018年6月12日 / MarketsandMarketsが発行した当調査レポートでは、血液分析装置・試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス別分析、価格別分析、需要先別分析、地域別分析、血液分析装置・試薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The hematology products market projected to grow at a CAGR of 8.5%.”The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. Technological advancements in hematology analyzers and reagents, integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain...

クレアチニン測定の世界市場予測（～2023年）：キット、試薬
BT-6361 / MarketsandMarkets / 2018年6月11日 / MarketsandMarketsが発行した当調査レポートでは、クレアチニン測定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（キット、試薬）別分析、テスト種類別分析、サンプル別分析、需要先別分析、クレアチニン測定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type,...

試験片有効性テストの世界市場予測（～2023年）
BT6295 / MarketsandMarkets / 2018年5月17日 / MarketsandMarketsが発行した当調査レポートでは、試験片有効性テストの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（試薬、コントロール、アッセイキット、消耗品）別分析、種類（実験室、POC検査）別分析、エンドユーザー別分析、地域別分析、試験片有効性テストの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global specimen validity testing market is projected to grow at 6.3% during the forecast period” The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.) “Specimen validity testing services are expected to grow...

イムノアッセイ（免疫学的検定）の世界市場予測（～2023年）：試薬・キット、分析装置、ソフトウェア
MD4751 / MarketsandMarkets / 2018年5月14日 / MarketsandMarketsが発行した当調査レポートでは、イムノアッセイ（免疫学的検定）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス（試薬・キット、分析装置、ソフトウェア）別分析、技術別分析、プラットフォーム別分析、用途別分析、イムノアッセイ（免疫学的検定）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. The global immunoassays market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share...

肝炎検査ソリューション・診断の世界市場予測（～2023年）
MAM-MD-6643 / MarketsandMarkets / 2018年10月2日 / MarketsandMarketsが発行した当調査レポートでは、肝炎検査ソリューション・診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、疾患別（B型肝炎、HCV、HAV、HDV）分析、技術別（ELISA、RDT、PCR、転写増幅法）分析、エンドユーザー別（病院、診断ラボ、血液バンク、介護施設）分析、肝炎検査ソリューション・診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global hepatitis test solution/diagnosis market is projected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period. This market is primarily driven by factors such as the high burden of hepatitis worldwide, increasing number of blood transfusions and donations, benefits offered by PoC instruments & kits, and awareness initiatives. Emerging markets such as China, India, Brazil, and Africa are expected to offer lucrative growth opportunities for the players in this market. However, the high cost of NAT tests and a lack of mandate for NAT in developing...

敗血症診断の世界市場予測（～2023年）：技術別、製品別、方法別、検査種類別、病原体別、エンドユーザー別、地域別分析
MAM-MD-4575 / MarketsandMarkets / 2018年4月5日 / MarketsandMarketsが発行した当調査レポートでは、敗血症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、方法別分析、検査種類別分析、敗血症診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The sepsis diagnostics market projected to grow at a CAGR of 9.1%.”The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the...

免疫蛍光測定アッセイの世界市場予測（～2023年）：試薬、一次抗体、二次抗体、キット、画像装置、顕微鏡
BT-6044 / MarketsandMarkets / 2018年2月28日 / MarketsandMarketsが発行した当調査レポートでは、免疫蛍光測定アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、疾患別分析、需要先別分析、免疫蛍光測定アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunofluorescence assay market is projected to reach USD 2.01 Billion by 2023 from USD 1.51 Billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market. The report analyzes the global immunofluorescence assay market by product, type, disease, end user, and region. On the basis of product, the reagents segment accounted for the largest share of the global immunofluorescence assay market in 2017. The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields,...

移植診断の世界市場予測（～2023年）
MD4870 / MarketsandMarkets / 2018年6月29日 / MarketsandMarketsが発行した当調査レポートでは、移植診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別（PCR、NGS、サンガー法シーケンシング）分析、製品別（機器、試薬、ソフトウェア）分析、用途別（HLA、血液プロファイリング、病原体検出）分析、タイプ別（心臓、腎臓、肝臓、幹細胞）分析、移植診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The transplant diagnostics market projected to grow at a CAGR of 7.4%.”The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆